Table 2 Cognitive functioning at baseline and after treatment with HF rTMS among the rs5275 genotypes.

From: A pilot study to examine the association between COX-2 rs5275 polymorphism and the response to repetitive transcranial stimulation in schizophrenia

 

Baseline (n = 44)

Week 4 (n = 44)

Group effect F(p)

Time effect F(p)

Group × Time F(p)

Immediate memory index

  

1.6(0.21)

39.1(<0.001)*

5.0(0.03)*

TT

51.3 ± 10.1

56.9 ± 12.3

   

C carriers

53.4 ± 14.7

65.3 ± 20.3

   

Visuospatial/constructional index

  

0.04(0.84)

4.8(0.04)*

0.002(0.96)

TT

68.9 ± 11.1

73.9 ± 13.5

   

C carriers

69.8 ± 5.6

74.6 ± 21.4

   

Language index

  

1.1(0.30)

4.1(0.05)

0.8(0.37)

TT

73.9 ± 16.3

77.4 ± 16.4

   

C carriers

79.9 ± 13.2

81.3 ± 14.3

   

Attention index

  

0.01(0.92)

0.3(0.60)

1.4(0.24)

TT

66.5 ± 14.3

64.7 ± 15.6

   

C carriers

64.8 ± 10.0

65.5 ± 9.8

   

Delayed memory index

  

5.0(0.03)*

20.9(<0.001)*

7.8(0.008)*

TT

56.6 ± 15.0

59.9 ± 15.9

   

C carriers

62.7 ± 16.7

76.3 ± 21.9

   

RBANS total score

  

5.9(0.02)*

48.1(<0.001)*

6.0(0.018)*

TT

54.4 ± 9.3

59.1 ± 10.3

   

C carriers

59.9 ± 11.2

69.7 ± 14.8

   
  1. *p < 0.05.